BioXcel Therapeutics, Inc.
BTAI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$59,599 | -$179,053 | -$165,757 | -$106,931 |
| Dep. & Amort. | $309 | $318 | $327 | $297 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6,156 | $18,614 | $17,337 | $19,455 |
| Change in WC | -$6,029 | $2,018 | $10,403 | $4,980 |
| Other Non-Cash | -$12,864 | $3,097 | $2,349 | $46 |
| Operating Cash Flow | -$72,027 | -$155,006 | -$135,341 | -$82,153 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$20 | -$139 | -$445 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$20 | -$139 | -$445 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2,500 | $0 | $98,600 | $0 |
| Stock Issued | $39,688 | $27,032 | $0 | $100,993 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$528 | -$510 | -$2,363 | $1,454 |
| Financing Cash Flow | $36,660 | $26,522 | $96,237 | $102,447 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$35,367 | -$128,504 | -$39,243 | $19,849 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $65,221 | $193,725 | $232,968 | $213,119 |
| End Cash | $29,854 | $65,221 | $193,725 | $232,968 |
| Free Cash Flow | -$72,027 | -$155,026 | -$135,480 | -$82,598 |